世界の腫瘍アブレーション市場(技術-高周波アブレーション、マイクロ波アブレーション、クリオアブレーション、高強度集束超音波、レーザー間質熱アブレーション;疾患-肝癌、肺癌、腎癌、骨癌、乳癌、前立腺癌;エンドユーザー-病院、がん専門クリニック)-グローバル産業分析、規模、シェア、成長、動向及び予測2014-2024

【英語タイトル】Tumor Ablation Market (Technology - Radiofrequency Ablation, Microwave Ablation, Cryoablation, High-Intensity Focused Ultrasound, and Laser Interstitial Thermal Ablation; Disease Indication - Liver Cancer, Lung Cancer, Kidney Cancer, Bone Cancer, Breast Cancer, and Prostate Cancer; End Users - Hospitals and Cancer Specialty Clinics) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2014 - 2024

Transparency Market Researchが出版した調査資料(TMR706154)・商品コード:TMR706154
・発行会社(調査会社):Transparency Market Research
・発行日:2017年3月22日
・ページ数:165
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single UserUSD5,795 ⇒換算¥643,245見積依頼/購入/質問フォーム
Multi UserUSD8,795 ⇒換算¥976,245見積依頼/購入/質問フォーム
Corporate LicenseUSD11,795 ⇒換算¥1,309,245見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
当調査レポートでは、世界の腫瘍アブレーション市場について調査・分析し、産業分析、世界の腫瘍アブレーション市場規模、市場シェア、成長、市場動向、予測データを含め、以下の構成でお届けいたします。
・世界の腫瘍アブレーション市場:序文
・世界の腫瘍アブレーション市場:エグゼクティブサマリー
・世界の腫瘍アブレーション市場:市場概要・動向
・世界の腫瘍アブレーション市場:セグメント別市場規模・分析
・世界の腫瘍アブレーション市場:地域別市場規模・分析
・世界の腫瘍アブレーション市場:関連企業分析
【レポートの概要】

Global Tumor Ablation Market: Overview

Tumor ablation is the removal of the tumor cells or tissue with minimally invasive procedure. Tumor ablation devices are consists of an applicator (catheter), which is introduced into the tumor under imaging guidance. For tumor ablation procedure Ultrasound (US) or Magnetic Resonance Imaging (MRI), Computed Tomography (CT), is used to guide and position the needle probe into the tumor. A detailed overview of market dynamics, including the drivers, restraints, and opportunities of the market, has been provided in this report. Market revenue for all the above mentioned segments, and their sub segments has been provided for the forecast period of 2016-2024, considering 2015 as the base year, and 2014 as the historical year, along with compound annual growth rate (CAGR %), for the forecast period of 2016-2024. Market share estimations were based on in-depth analysis and study of products, and their features, prices etc.

This report provides in-depth analysis of the market. The stakeholders for this report include companies involved in the manufacturing of ablation devices and its spares parts. For providing a snapshot of this market to the stakeholders, executive summary section is included in this report, which summarizes the market size, trends and competition in different regions. Market share analysis among the market players is analyzed to signify percentage share of the major players operating in the tumor ablation market. Furthermore, the report incorporates market attractiveness analysis by geography that depicts the most attractive and significant region in the global market in 2015.

The research methodology is a combination of primary and secondary research. Primary research includes information collected via e-mails, and telephonic interviews of Key Opinion Leaders (KOL), and forms the bulk of our research. Secondary research includes information collected from various sources, by study of company websites, annual reports, stock analysis presentations, press releases, and various national and international databases.

Global Tumor Ablation Market: Segmentation

Based on technology, global market is segmented on the basis of technology are radiofrequency ablation, microwave ablation, Cryoablation, high-intensity focused ultrasound, laser interstitial thermal ablation, and others. Based on disease indication, the market are segmented into liver cancer, lung cancer, kidney cancer, bone cancer, breast cancer, prostate cancer, and others. End users in the tumor ablation market are, hospitals, cancer specialty clinics, and others (long term care center, research, academics, nursing facility, etc.)

Based on geography, the market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. The regions are further segmented into major countries which include, U.S., Canada, Germany, U.K., France, Spain, Italy, Russia, rest of Europe, India, China, Japan, Australia and New Zealand, Rest of Asia Pacific, Brazil, Mexico, Rest of Latin America, GCC countries, South Africa and Rest of Middle East and Africa.

Companies Mentioned in the Report

The report also comprises list major players in the market, their SWOT analysis, market share of these players in the tumor ablation, key business strategies, product portfolios, and recent developments. Key market players profiled in this report include, Medtronic plc, Integra LifeSciences Holdings Corporation, BTG International Ltd, Boston Scientific Corporation, AngioDynamics, Inc., SonaCare Medical, LLC., BVM Medical Limited, St. Jude Medical, Inc., and EDAP TMS S.A.

The global tumor ablation market has been segmented as follows:

By Technology

Radiofrequency Ablation
Microwave Ablation
Cryoablation
High-Intensity Focused Ultrasound
Laser Interstitial Thermal Ablation
Others
By Material

Liver cancer
Lung cancer
Kidney cancer
Bone cancer
Breast cancer
Prostate cancer
Others
By End Users

Hospitals
Cancer Specialty Clinics
Others
By Geography

North America
U.S.
Canada
Europe
Germany
France
U.K.
Spain
Italy
Russia
Rest of Europe
Asia Pacific
India
China
Japan
Australia & New Zealand
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East and Africa
GCC countries
South Africa
Rest of MEA

【レポートの目次】

1. Preface

2. Research Methodology & Assumptions

3. Executive Summary

4. Global Tumor Ablation Products Market Overview
4.1 Introduction (Product Definition)
4.2 Industry Evolution/Development
4.3 Key Market Indicators
4.4 Market Dynamics
4.4.1 Drivers
4.4.2 Restraints
4.4.3 Opportunity
4.5 Global Market Analysis and Forecasts, 2014 – 2024
4.6 Global Market – Global Supply Demand Scenario
4.7 Porter’s Five Force Analysis
4.8 Value Chain Analysis
4.9 Market Outlook

5. Global Tumor Ablation Market Analysis and Forecast by Technology
5.1 Key Findings
5.2 Introduction
5.3 Market Size (US$ Mn) Forecast, By Technology
5.3.1 Radiofrequency Ablation
5.3.2 Microwave Ablation
5.3.3 Cryoablation
5.3.4 High-Intensity Focused Ultrasound
5.3.5 Laser Interstitial Thermal Ablation
5.3.6 Others
5.4 Market Attractiveness, By Technology
5.5 Key Trends

6. Global Tumor Ablation Market Analysis and Forecast by Disease Indication
6.1 Key Findings
6.2 Introduction
6.3 Market Size (US$ Mn) Forecast, By Disease Indication
6.3.1 Liver cancer
6.3.2 Lung cancer
6.3.3 Kidney cancer
6.3.4 Bone cancer
6.3.5 Breast cancer
6.3.6 Prostate cancer
6.3.7 Others
6.4 Market Attractiveness, By Disease Indication
6.5 Key Trends

7. Global Tumor Ablation Market Analysis and Forecast by End User
7.1 Key Findings
7.2 Introduction
7.3 Market Size (US$ Mn) Forecast, By End User
7.3.1 Home Users
7.3.2 Clinics
7.3.3 Hospitals
7.4 Market Attractiveness, By End User
7.5 Key Trends

8. Global Tumor Ablation Market Analysis and Forecast by Region
8.1 Key Findings
8.2 Introduction
8.2.1 Market Size (US$ Mn) Forecast, By Region
8.2.2 North America
8.2.3 Europe
8.2.4 Asia Pacific
8.2.5 Latin America
8.2.6 Middle East and Africa

9. North America Tumor Ablation Market Analysis and Forecast by Region
9.1 Key Findings
9.2 North America Market Forecast, by Technology
9.3 North America Market Forecast, by Disease Indication
9.4 North America Market Forecast, by End User
9.5 North America Market Forecast, by Country
9.5.1 U.S. Market Overview
9.5.2 Canada Market Overview
9.6 North America Market Attractiveness Analysis
9.7 Market Trends

10. Europe Tumor Ablation Market Analysis and Forecast by Region
10.1 Key Findings
10.2 Europe Market Forecast, by Technology
10.3 Europe Market Forecast, by Disease Indication
10.4 Europe Market Forecast, by End User
10.5 Europe Market Forecast, by Country
10.5.1 U.K. Market Overview
10.5.2 Germany Market Overview
10.5.3 France Market Overview
10.5.4 Italy Market Overview
10.5.5 Spain Market Overview
10.5.6 Russia Market Overview
10.5.7 Rest of Europe Market Overview
10.6 Europe Market Attractiveness Analysis
10.7 Market Trends

11. Asia Pacific Tumor Ablation Market Analysis and Forecast by Region
11.1 Key Findings
11.2 Asia Pacific Market Forecast, by Technology
11.3 Asia Pacific Market Forecast, by Disease Indication
11.4 Asia Pacific Market Forecast, by End User
11.5 Asia Pacific Market Forecast, by Country
11.5.1 India Market Overview
11.5.2 China Market Overview
11.5.3 Japan Market Overview
11.5.4 Australia of Asia Pacific Tumor Ablation Market Overview
11.5.5 Rest of APAC Tumor Ablation Market Overview
11.6 Asia Pacific Market Attractiveness Analysis
11.7 Market Trends

12 Latin America Tumor Ablation Market Analysis and Forecast by Region
12.1 Key Findings
12.2 Latin America Market Forecast, by Technology
12.3 Latin America Market Forecast, by Disease Indication
12.4 Latin America Market Forecast, by End User
12.5 Latin America Market Forecast, by Country
12.5.1 Brazil Tumor Ablation Market Overview
12.5.2 Mexico Tumor Ablation Market Overview
12.5.3 Rest of LATAM Tumor Ablation Market Overview
12.6 Latin America Market Attractiveness Analysis
12.7 Market Trends

13 Middle East and Africa Tumor Ablation Market Analysis and Forecast by Region
13.1 Key Findings
13.2 Middle East and Africa Market Forecast, by Technology
13.3 Middle East and Africa Market Forecast, by Disease Indication
13.4 Middle East and Africa Market Forecast, by End User
13.5 Middle East and Africa Market Forecast, by Country
13.5.1 South Africa Tumor Ablation Market Overview
13.5.2 GCC countries Tumor Ablation Market Overview
13.5.3 Rest of MEA Tumor Ablation Market Overview
13.6 Middle East and Africa Market Attractiveness Analysis
13.7 Market Trends

14. Competitive Landscape
14.1 Market Share Analysis, by Company
14.2 Competition Matrix
14.3 Company Profiles
14.3.1 Medtronic plc.
14.3.1.1 Company Details
14.3.1.2 Business Overview
14.3.1.3 Financial Overview
14.3.1.4 Strategic Overview
14.3.1.5 SWOT Analysis
14.3.2 Integra LifeSciences Holdings Corporation
14.3.2.1 Company Details
14.3.2.2 Business Overview
14.3.2.3 Financial Overview
14.3.2.4 Strategic Overview
14.3.2.5 SWOT Analysis
14.3.3 BTG International Ltd
14.3.3.1 Company Details
14.3.3.2 Business Overview
14.3.3.3 Financial Overview
14.3.3.4 Strategic Overview
14.3.3.5 SWOT Analysis
14.3.4 Boston Scientific Corporation
14.3.4.1 Company Details
14.3.4.2 Business Overview
14.3.4.3 Financial Overview
14.3.4.4 Strategic Overview
14.3.4.5 SWOT Analysis
14.3.5 AngioDynamics, Inc.
14.3.5.1 Company Details
14.3.5.2 Business Overview
14.3.5.3 Financial Overview
14.3.5.4 Strategic Overview
14.3.5.5 SWOT Analysis
14.3.6 SonaCare Medical, LLC.
14.3.6.1 Company Details
14.3.6.2 Business Overview
14.3.6.3 Financial Overview
14.3.6.4 Strategic Overview
14.3.6.5 SWOT Analysis
14.3.7 BVM Medical Limited
14.3.7.1 Company Details
14.3.7.2 Business Overview
14.3.7.3 Financial Overview
14.3.7.4 Strategic Overview
14.3.7.5 SWOT Analysis
14.3.8 St. Jude Medical, Inc.
14.3.8.1 Company Details
14.3.8.2 Business Overview
14.3.8.3 Financial Overview
14.3.8.4 Strategic Overview
14.3.8.5 SWOT Analysis
14.3.9 EDAP TMS S.A.
14.3.9.1 Company Details
14.3.9.2 Business Overview
14.3.9.3 Financial Overview
14.3.9.4 Strategic Overview
14.3.9.5 SWOT Analysis

List of Figures

Figure 01: Global Tumor Ablation Market Size (US$ Mn) Forecast, 2015–2024
Figure 02: Global Tumor Ablation Market Value Share Analysis by Technology, 2016 and 2024
Figure 03: Global Technology Market Revenue
Figure 04: Global Technology Market Revenue
Figure 05: Global Technology Market Revenue
Figure 06: Global Technology Market Revenue
Figure 07: Global Technology Market Revenue
Figure 08: Global Tumor Ablation Technology Market Revenue
Figure 09: Tumor Ablation Technology Market Attractiveness Analysis by Technology
Figure 10: Global Tumor Ablation Market Value Share Analysis by Disease Indication, 2016 and 2024
Figure 11: Global Tumor Ablation Disease Indication Market Revenue
Figure 12: Global Disease Indication Market Revenue
Figure 13: Global Disease Indication Market Revenue
Figure 14: Global Disease Indication Market Revenue
Figure 15: Global Disease Indication Market Revenue
Figure 16: Global Disease Indication Market Revenue
Figure 17: Global Disease Indication Market Revenue
Figure 18: Tumor Ablation Market Attractiveness Analysis by Disease Indication
Figure 19: Global Tumor Ablation Market Value Share Analysis by End User, 2016 and 2024
Figure 20: Global Home User Tumor Ablation Market Revenue
Figure 21: Global Clinics Tumor Ablation Market Revenue
Figure 22: Global Hospitals Tumor Ablation Market Revenue
Figure 23: Tumor Ablation Market Attractiveness Analysis by End User
Figure 24: Global Tumor Ablation Market Value Share Analysis by Region Type, 2016 and 2024
Figure 25: Tumor Ablation Market Attractiveness Analysis, By Region Type
Figure 26: North America Market Size (US$ Mn) Forecast, 2015–2024
Figure 27: North America Market Attractiveness Analysis by Country
Figure 28: North America Market Value Share Analysis by Technology, 2016 and 2024
Figure 29: North America Market Value Share Analysis by Disease Indication, 2016 and 2024
Figure 30: North America Market Value Share Analysis by End User, 2016 and 2024
Figure 31: North America Market Value Share Analysis by Country, 2016 and 2024
Figure 32: North America Market Attractiveness Analysis, By Disease Indication
Figure 33: North America Market Attractiveness Analysis, By Technology
Figure 34: North America Market Attractiveness Analysis, By End User
Figure 35: Europe Tumor Ablation Market Size (US$ Mn) Forecast, 2015–2024
Figure 36: Europe Market Attractiveness Analysis by Country
Figure 37: Europe Tumor Ablation Market Value Share Analysis by Technology, 2016 and 2024
Figure 38: Europe Tumor Ablation Market Value Share Analysis by Disease Indication, 2016 and 2024
Figure 39: Europe Tumor Ablation Market Value Share Analysis by End User, 2016 and 2024
Figure 40: Europe Market Value Share Analysis by Country, 2016 and 2024
Figure 41: Europe Market Attractiveness Analysis, By Disease Indication
Figure 42: Europe Market Attractiveness Analysis, By Technology
Figure 43: Europe Market Attractiveness Analysis, By End User
Figure 44: Asia Pacific Market Size (US$ Mn) Forecast, 2015–2024
Figure 45: Asia Pacific Market Attractiveness Analysis by Country
Figure 46: Asia Pacific Market Value Share Analysis by Technology, 2016 and 2024
Figure 47: Asia Pacific Tumor Ablation Market Value Share Analysis by Disease Indication, 2016 and 2024
Figure 48: Asia Pacific Market Value Share Analysis by End User, 2016 and 2024
Figure 49: Asia Pacific Market Value Share Analysis by Country, 2016 and 2024
Figure 50: Asia Pacific Market Attractiveness Analysis, By Disease Indication
Figure 51: Asia Pacific Market Attractiveness Analysis, By Technology
Figure 52: Asia Pacific Market Attractiveness Analysis, By End User
Figure 53: Latin America Tumor Ablation Market Size (US$ Mn) Forecast, 2015–2024
Figure 54: Latin America Market Attractiveness Analysis by Country
Figure 55: Latin America Tumor Ablation Market Value Share Analysis by Technology, 2016 and 2024
Figure 56: Latin America Tumor Ablation Market Value Share Analysis by Disease Indication, 2016 and 2024
Figure 57: Latin America Tumor Ablation Market Value Share Analysis by End User, 2016 and 2024
Figure 58: Latin America Market Value Share Analysis by Country, 2016 and 2024
Figure 59: Latin America Market Attractiveness Analysis, By Disease Indication
Figure 60: Latin America Market Attractiveness Analysis, By Technology
Figure 61: Latin America Market Attractiveness Analysis, By End User
Figure 62: MEA Tumor Ablation Market Size (US$ Mn) Forecast, 2015–2024
Figure 63: MEA Market Attractiveness Analysis by Country
Figure 64: MEA Market Value Share Analysis by Technology, 2016 and 2024
Figure 65: MEA Market Value Share Analysis by Disease Indication, 2016 and 2024
Figure 66: MEA Market Value Share Analysis by End User, 2016 and 2024
Figure 67: MEA Market Value Share Analysis by Country, 2016 and 2024
Figure 68: MEA Market Attractiveness Analysis, By Disease Indication
Figure 69: MEA Market Attractiveness Analysis, By Technology
Figure 70: MEA Market Attractiveness Analysis, By End User
Figure 71: Global Tumor Ablation Market Share Analysis by Company (2015)

List of Table

Table 01: Global Tumor Ablation Market Size (US$ Mn) Forecast, By Technology, 2016–2024
Table 02: Global Market Size (US$ Mn) Forecast, By Disease Indication, 2016–2024
Table 03: Global Tumor Ablation Market Size (US$ Mn) Forecast, By End User, 2016–2024
Table 04: Global Tumor Ablation Market Size (US$ Mn) Forecast, By Region Type, 2015–2024
Table 05: North America Tumor Ablation Market Size (US$ Mn) Forecast, By Technology, 2016–2024
Table 06: North America Market Size (US$ Mn) Forecast, By Disease Indication, 2016–2024
Table 07: North America Market Size (US$ Mn) Forecast, By End User, 2016–2024
Table 08: North America Tumor Ablation Market Size (US$ Mn) Forecast, By Country, 2016–2024
Table 09: Europe Tumor Ablation Market Size (US$ Mn) Forecast, By Technology, 2016–2024
Table 10: Europe Market Size (US$ Mn) Forecast, By Disease Indication, 2016–2024
Table 11: Europe Market Size (US$ Mn) Forecast, By End User, 2016–2024
Table 12: Europe Market Size (US$ Mn) Forecast, By Country, 2016–2024
Table 13: Asia Pacific Tumor Ablation Market Size (US$ Mn) Forecast, By Technology, 2016–2024
Table 14: Asia Pacific Market Size (US$ Mn) Forecast, By Disease Indication, 2016–2024
Table 15: Asia Pacific Market Size (US$ Mn) Forecast, By End User, 2016–2024
Table 16: Asia Pacific Market Size (US$ Mn) Forecast, By Country, 2016–2024
Table 17: Latin America Tumor Ablation Market Size (US$ Mn) Forecast, By Technology, 2016–2024
Table 18: Latin America Tumor Ablation Market Size (US$ Mn) Forecast, By Disease Indication, 2016–2024
Table 19: Latin America Tumor Ablation Market Size (US$ Mn) Forecast, By End User, 2016–2024
Table 20: Latin America Market Size (US$ Mn) Forecast, By Country, 2016–2024
Table 21: MEA Tumor Ablation Market Size (US$ Mn) Forecast, By Technology, 2016–2024
Table 22: MEA Market Size (US$ Mn) Forecast, By Disease Indication, 2016–2024
Table 23: MEA Tumor Ablation Market Size (US$ Mn) Forecast, By End User, 2016–2024
Table 24: MEA Market Size (US$ Mn) Forecast, By Country, 2016–2024



★調査レポート[世界の腫瘍アブレーション市場(技術-高周波アブレーション、マイクロ波アブレーション、クリオアブレーション、高強度集束超音波、レーザー間質熱アブレーション;疾患-肝癌、肺癌、腎癌、骨癌、乳癌、前立腺癌;エンドユーザー-病院、がん専門クリニック)-グローバル産業分析、規模、シェア、成長、動向及び予測2014-2024] (コード:TMR706154)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の腫瘍アブレーション市場(技術-高周波アブレーション、マイクロ波アブレーション、クリオアブレーション、高強度集束超音波、レーザー間質熱アブレーション;疾患-肝癌、肺癌、腎癌、骨癌、乳癌、前立腺癌;エンドユーザー-病院、がん専門クリニック)-グローバル産業分析、規模、シェア、成長、動向及び予測2014-2024]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆